Last update: Oct. 9, 2016
Minimal risk for breastfeeding and infant.
Its high plasma protein-binding capacity would explain the very low excretion observed into breast milk (Houwert-de Jong 1981, Nava 2004).
No clinical side-effects and/or blood test disarrangements were observed in infants whose mothers were treated with acenocoumarol (Houwert-de Jong 1981, Fondevila 1989).
We do not have alternatives for Acenocoumarol since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2021 from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM